Open AccessHistamine: an undercover agent in multiple rare diseases?
Author(s) -
PinoÁngeles Almudena,
ReyesPalomares Armando,
Melgarejo Esther,
SánchezJiménez Francisca
Publication year - 2012
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/j.1582-4934.2012.01566.x
Subject(s) - histamine , histamine receptor , histidine decarboxylase , immune system , receptor , bioinformatics , biology , computational biology , neuroscience , medicine , pharmacology , immunology , histidine , biochemistry , amino acid , antagonist
Histamine is a biogenic amine performing pleiotropic effects in humans, involving tasks within the immune and neuroendocrine systems, neurotransmission, gastric secretion, cell life and death, and development. It is the product of the histidine decarboxylase activity, and its effects are mainly mediated through four different G‐protein coupled receptors. Thus, histamine‐related effects are the results of highly interconnected and tissue‐specific signalling networks. Consequently, alterations in histamine‐related factors could be an important part in the cause of multiple rare/orphan diseases. Bearing this hypothesis in mind, more than 25 rare diseases related to histamine physiopathology have been identified using a computationally assisted text mining approach. These newly integrated data will provide insight to elucidate the molecular causes of these rare diseases. The data can also help in devising new intervention strategies for personalized medicine for multiple rare diseases.